Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Campisi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2020
3D Self-Organized Human Blood-Brain Barrier in a Microfluidic ChipMarco Campisi, Sei Hien Lim, Valeria Chiono, et al.
Advanced Healthcare Materials|September 8, 2017
In Vitro Microfluidic Models for Neurodegenerative DisordersTatsuya Osaki, Yoojin Shin, Vivek Sivathanu, et al.
Biomicrofluidics|June 12, 2018
<i>In vitro</i> models of molecular and nano-particle transport across the blood-brain barrierCynthia Hajal, Marco Campisi, Clara Mattu, et al.
Biomaterials|July 23, 2018
3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytesMarco Campisi, Yoojin Shin, Tatsuya Osaki, et al.
Cancers|July 27, 2022
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer ImmunotherapiesMarco Campisi, Sarah E Shelton, Minyue Chen, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
miR126-mediated impaired vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Molecular Psychiatry|February 18, 2026
miR126-mediated alteration of vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2019
MicroRNA delivery through nanoparticlesSharon Wei Ling Lee, Camilla Paoletti, Marco Campisi, et al.
Advanced Healthcare Materials|March 4, 2020
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier MicrovasculatureSharon Wei Ling Lee, Marco Campisi, Tatsuya Osaki, et al.
Cancer Immunology Research|September 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint BlockadeSaba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2020
3D Self-Organized Human Blood-Brain Barrier in a Microfluidic ChipMarco Campisi, Sei Hien Lim, Valeria Chiono, et al.
Advanced Healthcare Materials|September 8, 2017
In Vitro Microfluidic Models for Neurodegenerative DisordersTatsuya Osaki, Yoojin Shin, Vivek Sivathanu, et al.
Biomicrofluidics|June 12, 2018
<i>In vitro</i> models of molecular and nano-particle transport across the blood-brain barrierCynthia Hajal, Marco Campisi, Clara Mattu, et al.
Biomaterials|July 23, 2018
3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytesMarco Campisi, Yoojin Shin, Tatsuya Osaki, et al.
Cancers|July 27, 2022
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer ImmunotherapiesMarco Campisi, Sarah E Shelton, Minyue Chen, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
miR126-mediated impaired vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Molecular Psychiatry|February 18, 2026
miR126-mediated alteration of vascular integrity in Rett syndromeTatsuya Osaki, Zhengpeng Wan, Koji Haratani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2019
MicroRNA delivery through nanoparticlesSharon Wei Ling Lee, Camilla Paoletti, Marco Campisi, et al.
Advanced Healthcare Materials|March 4, 2020
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier MicrovasculatureSharon Wei Ling Lee, Marco Campisi, Tatsuya Osaki, et al.
Cancer Immunology Research|September 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint BlockadeSaba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, et al.
Pageof 3